A 2025 early clinical study involving 15 volunteers found that a single infusion of an experimental CRISPR-based gene-editing drug reduced cholesterol levels and harmful triglyceride levels by about 50%.
November 08, 2025
high
temporal
Early-phase clinical study reporting lipid-lowering effects of a CRISPR-based therapeutic.
By 2025, CRISPR genome editing had accelerated xenotransplantation efforts by enabling targeted genetic modifications in pigs to make their organs more suitable for human transplantation.
May 29, 2025
high
temporal
Describes the role of CRISPR in enabling genetic modifications of pigs for organ transplant research.